Jones Nauseef
Company: Convergent Therapeutics
Job title: Senior Medical Director
Seminars:
Update on PSMA-Directed Actinium Labeled Radioantibody Therapy 1:00 pm
Exploring the rationale for using antibodies when targeting PSMA with Actinium-225 Uncovering activity of CONV01-a monotherapy in advanced prostate cancer Sharing activity of CONV01- a combination therapies in advanced prostate cancerRead more
day: Day Two ESC PM